top of page

Our Journey

We are at the forefront of creating an innovative early-cancer diagnostic system. We take pride in reshaping the landscape of cancer diagnosis, offering precise, dependable, cost-effective and rapid screening services, including same-day results

OUR SERVICES

How We Detect Cancer Early

Using a novel vibrational spectroscopy approach and machine learning, we successfully conducted a clinical pilot study and were able to classify stage I cancer in liquid biopsy with accuracies above 95%. Our approach has the potential to be applied in asymptomatic routine screening of cancer as well as for triaging of patients who present with non-specific symptoms.

Image by National Cancer Institute

ROADMAP

2018

CONCEPTUALIZATION

Diverngulux came to life in the world of ideas

2019

RESEARCH, DESIGN AND PROTOTYPING

Our team of experts developed and designed a prototype

bottom of page